06/08CDMO contract for entering non-clinical and clinical test of APB-A001 (Binex)
01/17Website Renewal
12/03Office Relocation (Tera Tower 1, Munjeong-dong, Songpa-gu)
11/26Research Institute Cerificate
08/22Venture Company Certificate
08/21Six Trademark Applications (South Korea)
08/08Signed Technology Transfer Agreement. MOU with the Kangwon National University Industry Cooperation Foundation
07/23Seed Investor Agreement (Kolon Investment : 2 billion KRW, Neoplux : 2 billion KRW
07/22T-cell receptor(TCR) Study Contract with Charles River
06/27PCT Patent Application for target immuno-therapeutics
06/24U.S.Provisional Patents Application for target immuno-therapeutics
06/14Small and Medium-sized Enterprise Certificate
05/13Office Relocation (Munjeong-dong, Songpa-gu, Seoul)
03/26Strategic Investment Contract (C&R Research Inc. : 500 million KRW)
03/04Technology Transfer Agreement : Target Immuno-therapeutics (The Industry Academy Cooperation Foundation of Kangwon National University Technology)
12/13Establishment of APITBIO Inc. (Daechi-dong, Gangnam-gu, Seoul)